Compare · APGB vs TENK
APGB vs TENK
Side-by-side comparison of Apollo Strategic Growth Capital II (APGB) and TenX Keane Acquisition (TENK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APGB and TENK operate in Blank Checks (Finance), so they compete in similar markets.
- APGB carries a market cap of $836.6M.
APGB
Apollo Strategic Growth Capital II
Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
Latest APGB
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G filed by Apollo Strategic Growth Capital II
- SEC Form 15-12G filed by Apollo Strategic Growth Capital II
- SEC Form 25-NSE filed by Apollo Strategic Growth Capital II
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
- Apollo Strategic Growth Capital II filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Per-Share Redemption Price For The Public Shares Will Be ~$10.58
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
Latest TENK
- Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition
- SEC Form 4 filed by Director Dutia Suren G
- SEC Form 4 filed by Director Holubiak Myron Z
- SEC Form 4 filed by Chief Medical Officer Czuczman Myron
- SEC Form 4 filed by Chief Executive Officer Mazur Leonard L
- SEC Form 4 filed by Chief Financial Officer Bartushak Jaime
- SEC Form 4 filed by Director Mcgrath Dennis M
- SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.
- SEC Form 4 filed by Director Webb Carol
- SEC Form 3 filed by new insider Dutia Suren G